That's US$34m (~A$45m) => (NPAT)PER closer to 7 than 10;
If you allow 100m for non operational componet of valuation (ie Toliara), then NPAT PER ~ 4.44.
Seems a little heavily discounted relative to some of its operating peers...
An EBITDA margin ~ 55% ... seems pretty healthy to me ...
Have a great day
Ann: Presentation - FY18 Results, page-6
Add BSE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $313.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BSE (ASX) Chart |
Day chart unavailable
